[{"address1": "18702 N. Creek Parkway", "address2": "Suite 100", "city": "Bothell", "state": "WA", "zip": "98011", "country": "United States", "phone": "610 321 3700", "website": "https://immunome.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immunome, Inc., a biotechnology company, develops targeted cancer therapies. The company's clinical asset comprises AL102, an investigational gamma secretase inhibitor currently in evaluation in a Phase 3 trial for the treatment of desmoid tumors; and preclinical assets consist of IM-1021, a receptor tyrosine kinase-like orphan receptor 1 and antibody-drug conjugates, as well as IM-3050, a fibroblast activation protein targeted radioligand therapy; and IM-4320, an anti-IL-38 immunotherapy candidate. Immunome, Inc. was incorporated in 2006 and is based in Bothell, Washington.", "fullTimeEmployees": 78, "companyOfficers": [{"maxAge": 1, "name": "Dr. Clay B. Siegall Ph.D.", "age": 62, "title": "President, CEO & Chairman", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1433088, "exercisedValue": 0, "unexercisedValue": 12996163}, {"maxAge": 1, "name": "Dr. Jack  Higgins Ph.D.", "age": 43, "title": "Chief Scientific Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 956342, "exercisedValue": 0, "unexercisedValue": 734891}, {"maxAge": 1, "name": "Dr. Robert J. Lechleider M.D.", "age": 62, "title": "Chief Medical Officer", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 512488, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Max  Rosett", "age": 33, "title": "Executive VP of Operations, Principal Accounting & Financial Officer and CFO", "yearBorn": 1990, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Philip  Tsai", "title": "Chief Technical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sandra G. Stoneman Esq., J.D.", "age": 50, "title": "Chief Legal Officer, General Counsel & Corporate Secretary", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 443432, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bruce  Turner M.D., Ph.D.", "age": 59, "title": "Chief Strategy Officer", "yearBorn": 1964, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kinney  Horn", "age": 48, "title": "Chief Business Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 9, "compensationRisk": 10, "shareHolderRightsRisk": 7, "overallRisk": 10, "governanceEpochDate": 1722470400, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 13.53, "open": 13.65, "dayLow": 13.13, "dayHigh": 13.65, "regularMarketPreviousClose": 13.53, "regularMarketOpen": 13.65, "regularMarketDayLow": 13.13, "regularMarketDayHigh": 13.65, "beta": 1.788, "forwardPE": -4.6551723, "volume": 459064, "regularMarketVolume": 459064, "averageVolume": 933650, "averageVolume10days": 670670, "averageDailyVolume10Day": 670670, "bid": 13.45, "ask": 13.59, "bidSize": 200, "askSize": 100, "marketCap": 810734400, "fiftyTwoWeekLow": 6.13, "fiftyTwoWeekHigh": 30.958, "priceToSalesTrailing12Months": 75.179375, "fiftyDayAverage": 13.7249, "twoHundredDayAverage": 15.126225, "currency": "USD", "enterpriseValue": 535153024, "floatShares": 42953890, "sharesOutstanding": 60054400, "sharesShort": 13779491, "sharesShortPriorMonth": 11236428, "sharesShortPreviousMonthDate": 1719532800, "dateShortInterest": 1722384000, "sharesPercentSharesOut": 0.2298, "heldPercentInsiders": 0.17058, "heldPercentInstitutions": 0.68702006, "shortRatio": 22.31, "shortPercentOfFloat": 0.24309999, "impliedSharesOutstanding": 60054400, "bookValue": 4.23, "priceToBook": 3.1914895, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -262592992, "trailingEps": -7.54, "forwardEps": -2.9, "enterpriseToRevenue": 49.625, "enterpriseToEbitda": -7.479, "52WeekChange": 0.92857146, "SandP52WeekChange": 0.24822903, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "IMNM", "underlyingSymbol": "IMNM", "shortName": "Immunome, Inc.", "longName": "Immunome, Inc.", "firstTradeDateEpochUtc": 1601645400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "c2147e86-3bc9-3a00-bf6a-53fc4499717d", "messageBoardId": "finmb_108518404", "gmtOffSetMilliseconds": -14400000, "currentPrice": 13.5, "targetHighPrice": 38.0, "targetLowPrice": 23.0, "targetMeanPrice": 32.25, "targetMedianPrice": 34.0, "recommendationMean": 1.5, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 278352992, "totalCashPerShare": 4.635, "ebitda": -71558000, "totalDebt": 2772000, "quickRatio": 6.976, "currentRatio": 7.125, "totalRevenue": 10784000, "debtToEquity": 1.092, "revenuePerShare": 0.259, "returnOnAssets": -0.2685, "returnOnEquity": -1.9955701, "freeCashflow": -72661752, "operatingCashflow": -60640000, "revenueGrowth": -0.445, "operatingMargins": -14.25423, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-15"}]